Follow
Daniel W Chan, Ph.D., DABCC, FACB
Daniel W Chan, Ph.D., DABCC, FACB
Professor of Pathology, Oncology, Radiology, Urology, Johns Hopkins University
Verified email at jhmi.edu - Homepage
Title
Cited by
Cited by
Year
Natural history of progression after PSA elevation following radical prostatectomy
CR Pound, AW Partin, MA Eisenberger, DW Chan, JD Pearson, PC Walsh
Jama 281 (17), 1591-1597, 1999
37751999
Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease
HB Carter, JD Pearson, EJ Metter, LJ Brant, DW Chan, R Andres, ...
Jama 267 (16), 2215-2220, 1992
16361992
The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer
AW Partin, J Yoo, HB Carter, JD Pearson, DW Chan, JI Epstein, PC Walsh
The Journal of urology 150 (1), 110-114, 1993
16321993
Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer
J Li, Z Zhang, J Rosenzweig, YY Wang, DW Chan
Clinical chemistry 48 (8), 1296-1304, 2002
13912002
Three biomarkers identified from serum proteomic analysis for the detection of early stage ovarian cancer
Z Zhang, RC Bast Jr, Y Yu, J Li, LJ Sokoll, AJ Rai, JM Rosenzweig, ...
Cancer research 64 (16), 5882-5890, 2004
13152004
Immunosensors—principles and applications to clinical chemistry
PB Luppa, LJ Sokoll, DW Chan
Clinica chimica acta 314 (1-2), 1-26, 2001
10382001
Overview of the HUPO Plasma Proteome Project: results from the pilot phase with 35 collaborating laboratories and multiple analytical groups, generating a core dataset of 3020 …
GS Omenn, DJ States, M Adamski, TW Blackwell, R Menon, H Hermjakob, ...
Proteomics 5 (13), 3226-3245, 2005
9362005
Integrated proteogenomic characterization of human high-grade serous ovarian cancer
H Zhang, T Liu, Z Zhang, SH Payne, B Zhang, JE McDermott, JY Zhou, ...
Cell 166 (3), 755-765, 2016
9232016
Prostate specific antigen in the staging of localized prostate cancer: influence of tumor differentiation, tumor volume and benign hyperplasia
AW Partin, HB Carter, DW Chan, JI Epstein, JE Oesterling, RC Rock, ...
The Journal of urology 143 (4), 747-752, 1990
8731990
National Academy of Clinical Biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers
CM Sturgeon, MJ Duffy, UH Stenman, H Lilja, N Brunner, DW Chan, ...
Clinical chemistry 54 (12), e11-e79, 2008
841*2008
Standard operating procedures for serum and plasma collection: early detection research network consensus statement standard operating procedure integration working group
MK Tuck, DW Chan, D Chia, AK Godwin, WE Grizzle, KE Krueger, W Rom, ...
Journal of proteome research 8 (1), 113-117, 2009
8062009
Prostate specific antigen in the preoperative and postoperative evaluation of localized prostatic cancer treated with radical prostatectomy
JE Oesterling, DW Chan, JI Epstein, AW Kimball Jr, DJ Bruzek, RC Rock, ...
The Journal of urology 139 (4), 766-772, 1988
7221988
HUPO Plasma Proteome Project specimen collection and handling: towards the standardization of parameters for plasma proteome samples
AJ Rai, CA Gelfand, BC Haywood, DJ Warunek, J Yi, MD Schuchard, ...
Proteomics 5 (13), 3262-3277, 2005
6192005
A multicenter study of [-2] pro-prostate specific antigen combined with prostate specific antigen and free prostate specific antigen for prostate cancer detection in the 2.0 to …
WJ Catalona, AW Partin, MG Sanda, JT Wei, GG Klee, CH Bangma, ...
The Journal of urology 185 (5), 1650-1655, 2011
6002011
Proteogenomic analysis of human colon cancer reveals new therapeutic opportunities
S Vasaikar, C Huang, X Wang, VA Petyuk, SR Savage, B Wen, Y Dou, ...
Cell 177 (4), 1035-1049. e19, 2019
5922019
Targeted peptide measurements in biology and medicine: best practices for mass spectrometry-based assay development using a fit-for-purpose approach
SA Carr, SE Abbatiello, BL Ackermann, C Borchers, B Domon, ...
Molecular & Cellular Proteomics 13 (3), 907-917, 2014
5632014
Multi-laboratory assessment of reproducibility, qualitative and quantitative performance of SWATH-mass spectrometry
BC Collins, CL Hunter, Y Liu, B Schilling, G Rosenberger, SL Bader, ...
Nature communications 8 (1), 291, 2017
5292017
Identification of hepatocarcinoma-intestine-pancreas/pancreatitis-associated protein I as a biomarker for pancreatic ductal adenocarcinoma by protein biochip technology
C Rosty, L Christa, S Kuzdzal, WM Baldwin, ML Zahurak, F Carnot, ...
Cancer research 62 (6), 1868-1875, 2002
5092002
Translation of proteomic biomarkers into FDA approved cancer diagnostics: issues and challenges
AK Füzéry, J Levin, MM Chan, DW Chan
Clinical proteomics 10, 1-14, 2013
5042013
Proteogenomic characterization reveals therapeutic vulnerabilities in lung adenocarcinoma
MA Gillette, S Satpathy, S Cao, SM Dhanasekaran, SV Vasaikar, K Krug, ...
Cell 182 (1), 200-225. e35, 2020
4852020
The system can't perform the operation now. Try again later.
Articles 1–20